US2011288467A1PendingUtilityA1
Method and apparatus for delivery of therapeutic agents
Est. expiryApr 5, 2022(expired)· nominal 20-yr term from priority
A61M 5/326A61M 5/20A61M 5/30A61M 2005/206A61M 5/2033A61M 5/2053A61N 1/306A61N 1/30A61M 5/46
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and apparatus for the reproducible, consistent and efficacious delivery of a therapeutic agent to a patient. The invention includes controlled administration of the therapeutic agent through an orifice to the patient, a plurality of penetrating electrodes arranged with a predetermined spatial relationship relative to the orifice, and an electrical signal generator operatively connected to the electrodes.
Claims
exact text as granted — not AI-modified1 - 20 . (canceled)
21 . An apparatus for the intracellular delivery of a therapeutic agent to a predetermined site within the tissue of a patient comprising:
means for the administration of said therapeutic agent to said patient comprising a reservoir for the therapeutic agent, at least one orifice through which the agent is administered, and an inanimate source of energy sufficient to transfer a predetermined amount of the therapeutic agent from said reservoir through said orifice to the predetermined site within the tissue of the patient; a plurality of penetrating electrodes arranged with a predetermined spatial relationship relative to said orifice; and means configured for generating an electrical field which facilitates the intracellular delivery of said therapeutic agent said means operatively connected to said electrodes.
22 . The apparatus as recited in claim 21 wherein the electrodes comprise a subassembly that can be separated from the orifice.
23 . The apparatus as recited in claim 21 further comprising means for adjusting the predetermined spatial relationship between said electrodes and said orifice.
24 . The apparatus as recited in claim 23 wherein said means for adjusting the spatial relationship comprises a source of energy.
25 . The apparatus as recited in claim 21 wherein the electrodes comprise a conductive, electrochemically stable compound.
26 . The apparatus as recited in claim 21 wherein the electrodes comprise a conductive metal coated with a conductive, electrochemically stable compound.
27 . The apparatus as recited in claim 25 wherein said conductive, electrochemically stable compound consists of at least one of the following materials: titanium nitride, platinum, platinum iridium, iridium oxide.
28 . The apparatus as recited in claim 21 wherein the means for administration of the therapeutic agent is a jet injector.
29 . The apparatus as recited in claim 28 wherein the source of energy to transfer the therapeutic agent is at least one compressed gas.
30 . The apparatus as recited in claim 28 wherein the source of energy to transfer the therapeutic agent is at least one spring.
31 . The apparatus as recited in claim 28 wherein the jet injector comprises means for controlling the rate at which the agent is transferred through the orifice.
32 . The apparatus as recited in claim 21 wherein the means for administration of the therapeutic agent is an automatic injection device.
33 . The apparatus as recited in claim 32 wherein said reservoir is a syringe including a penetrating hypodermic needle.
34 . The apparatus as recited in claim 32 wherein the source of energy to transfer the therapeutic agent is at least one compressed gas.
35 . The apparatus as recited in claim 32 wherein the source of energy to transfer the therapeutic agent is at least one spring.
36 . The apparatus as recited in claim 33 wherein the automatic injection device comprises means for controlling the depth of penetration of said needle into the patient.
37 . The apparatus as recited in claim 32 wherein the automatic injection device comprises means for controlling the rate at which the agent is transferred through the orifice.
38 . The apparatus as recited in claim 26 wherein said conductive, electrochemically stable compound consists of at least one of the following materials: titanium nitride, platinum, platinum iridium, iridium oxide.
39 . The apparatus as recited in claim 21 wherein the means for generating an electrical field is configured to induce an electrical field of from approximately 50 to approximately 300 V/cm between at least two of said electrodes.
40 . The apparatus as recited in claim 21 wherein die means for generating an electrical field is configured to deliver a signal for a duration of from approximately 1 microsecond to approximately 100 milliseconds and at a frequency of from approximately 0.1 Hertz to approximately 1 megahertz to at least two of said electrodes.Join the waitlist — get patent alerts
Track US2011288467A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.